paclitaxel has been researched along with Carcinoma, Medullary in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Matrana, M; Ryan, A; Tawagi, K; VanderVeen, N; Vasquez, R | 1 |
| Lu, WB; Ni, XC; Sun, SP; Sun, ZQ; Wang, J; Wang, JL; Yu, JP | 1 |
| Alazraki, A; Carden, MA; Meany, H; Rapkin, LB; Smith, S; Yin, H | 1 |
| Bockisch, A; Dralle, H; Kegel, T; Mann, K; Matuszczyk, A; Petersenn, S; Schmoll, HJ; Voigt, W | 1 |
| Breidenbach, M; Duda, V; Eichler, C; Gossmann, A; Harbeck, N; Hoopmann, M; Kates, RE; Ohlinger, R; Thomas, A; Warm, M | 1 |
| Coleman, T; Gangireddy, Vg; Liles, GB; Sostre, GD | 1 |
| Barbet, J; Campion, L; Chatal, JF; Chérel, M; Faivre-Chauvet, A; Kraeber-Bodéré, F; Mirallié, E; Saï-Maurel, C; Supiot, S; Thédrez, P | 1 |
| Hamilton, G; Kaczirek, K; Mittlböck, M; Niederle, B; Passler, C; Pfragner, R; Prager, G; Raderer, M; Scheuba, C; Schindl, M; Siegl, V; Weinhäusel, A | 1 |
| Bell, MD | 1 |
| Adachi, I; Aoyama, H; Horikoshi, N; Narabayashi, M; Taguchi, T; Takashima, S; Watanabe, T | 1 |
| Goldenberg, DM; Juweid, M; Stein, R; Zhang, CH | 1 |
2 trial(s) available for paclitaxel and Carcinoma, Medullary
| Article | Year |
|---|---|
Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epithelium.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Medullary; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Thyroid Neoplasms | 2010 |
A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Carcinoma, Medullary; Carcinoma, Papillary; Docetaxel; Female; Humans; Infusions, Intravenous; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Taxoids; Toxicity Tests | 1996 |
9 other study(ies) available for paclitaxel and Carcinoma, Medullary
| Article | Year |
|---|---|
Combination Therapy With Bortezomib in Renal Medullary Carcinoma: A Case Series.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Carcinoma, Medullary; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Nephrectomy; Paclitaxel | 2021 |
Pathologic response during chemo-radiotherapy and variation of serum VEGF levels could predict effects of chemo-radiotherapy in patients with esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Medullary; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Survival Rate; Vascular Endothelial Growth Factor A | 2015 |
Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases.
Topics: Adolescent; Anemia, Sickle Cell; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Carcinoma, Medullary; Child; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Paclitaxel | 2017 |
3D breast ultrasound: a significant predictor in breast cancer reduction under pre-operative chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Imaging, Three-Dimensional; Middle Aged; Neoplasm Staging; Paclitaxel; Preoperative Care; Prognosis; Remission Induction; Ultrasonography, Mammary | 2011 |
Response of metastatic renal medullary carcinoma to carboplatinum and Paclitaxel chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Carcinoma, Medullary; Fatal Outcome; Humans; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Sickle Cell Trait; Treatment Outcome | 2012 |
Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.
Topics: Animals; Antibodies, Bispecific; Carcinoembryonic Antigen; Carcinoma, Medullary; Combined Modality Therapy; Doxorubicin; Humans; Immunoglobulin G; Iodine Radioisotopes; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Pentetic Acid; Radiation-Sensitizing Agents; Radioimmunotherapy; Thyroid Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Medullary; Cell Line, Tumor; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Humans; Paclitaxel; Thyroid Neoplasms | 2004 |
Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Cisplatin; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Kidney Medulla; Kidney Neoplasms; Male; Paclitaxel | 2006 |
Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Medullary; Combined Modality Therapy; Doxorubicin; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Radioimmunotherapy; Thyroid Neoplasms; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Yttrium Radioisotopes | 1999 |